Skip to main content
TipRanks
Go Ultimate75% OFF

DuPont de Nemours (0A6B) AI Stock Analysis

6 Followers
GB:0A6B

DuPont de Nemours

(LSE:0A6B)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Margin Expansion and GuidanceImproving margins alongside raised EBITDA and cash-conversion guidance indicates that pricing, productivity, and operating discipline are translating into stronger earnings quality. If sustained, these actions can provide durable earnings support even while some end markets remain subdued.
Negative Factors
Declining Revenue BaseThe sharp TTM revenue decline indicates that improved profitability has not yet been matched by a durable top-line recovery. A smaller revenue base can limit operating leverage and leave future earnings more sensitive to volume recovery in cyclical markets.

DuPont de Nemours (0A6B) vs. iShares MSCI United Kingdom ETF (EWC)

0%5%10%15%20%25%30%35%40%GB:0A6B+25.10%EWC+16.25%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$19.90B
Dividend Yield
1.71%
Average Volume (3M)
152
Price to Earnings (P/E)
66.8
Beta (1Y)
1.25
Revenue Growth
-43.45%
EPS Growth
―
Country
UK
Employees
15,000
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals

DuPont de Nemours Business Overview & Revenue Model

Company Description

DuPont de Nemours, Inc. is a global provider of advanced materials and innovative solutions, serving markets across North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific region. The company's operations are organized int...

DuPont de Nemours Earnings Call Summary

Earnings Call Date:Nov 03, 2026(Q3-2026)|% Change Since:0.00%|Next Earnings Date:Feb 09, 2027
Earnings Call SentimentPositive

The call was strongly positive. DuPont exceeded third-quarter guidance, raised full-year sales, EBITDA, and EPS expectations, delivered broad-based organic growth, expanded margins, generated strong cash flow, and highlighted substantial productivity, innovation, AI, aerospace, healthcare, water, and EV battery opportunities. The principal challenges were Middle East project delays, currency and oil-and-gas-related headwinds, weakness in construction and automotive markets, and operational metrics such as OTIF that remain below target, but management stated that pricing and productivity actions were offsetting key cost pressures.

Positive Updates

Third-Quarter Results Exceeded Guidance
DuPont reported broad-based sales growth and continued productivity improvements, delivering 5% organic growth, 90 basis points of margin expansion, 31% adjusted EPS growth, and robust free cash flow conversion in the quarter.

Negative Updates

Middle East Disruptions Weighed on Water
Water sales were partially offset by continued disruptions in the Middle East. Excluding the Middle East, water organic sales increased mid-single digits in the quarter, while the full-year water outlook includes approximately 1% organic growth after the impact of pushed-out projects.

Company Guidance

For full year 2026, DuPont expects organic growth to be approximately 4.5%, sales to be about $7.19 billion, operating EBITDA of $1.785 billion, operating EBITDA growth of about 40% incremental, operating EBITDA margin of 24.8%, an 80 basis point improvement year-over-year, adjusted EPS at the midpoint of $7.50, a $0.25 increase versus prior guidance and a 22% increase compared to the prior year pro forma, and full-year free cash flow conversion of approximately 100% versus its 90% target; pricing is now closer to $110 million versus the $90 million previously discussed, and the guidance assumes large water projects in the Middle East will be pushed into 2027. For the fourth quarter, net sales are estimated at $1.825 billion with organic growth of about 8% year-over-year and currency neutral, operating EBITDA is expected to be $455 million with a 24.9% margin, adjusted EPS is expected to be in the range of $1.90 to $1.95 per share, representing an increase of 17%-19% compared to the prior year pro forma, and organic sales growth is expected to be in the high single digits percent range for both Healthcare & Water Technologies and Diversified Industrials.

DuPont de Nemours Risk Analysis

DuPont de Nemours disclosed 24 risk factors in its most recent earnings report. DuPont de Nemours reported the most risks in the "Legal & Regulatory" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Legal & Regulatory - Litigation, compliance, new legislation, and taxation risks

Latest Risks Added

2 New Risks
1.The timing and outcome of the Aramids Divestiture is subject to risk and uncertainties.Q4, 2025
2.In connection with the Qnity Distribution, certain liabilities are allocated to or retained by DuPont through assumption or indemnification of Qnity. If DuPont is required to make payments pursuant to these indemnities to Qnity, DuPont may need to divert cash to meet those obligations, and the Company's financial results could be negatively impacted. In addition, certain liabilities (including Qnity's Applicable Percentage of any Legacy Liabilities (as defined in the Electronics Separation and Distribution Agreement)) are allocated to or retained by Qnity through assumption or indemnification of DuPont. These indemnities may not be sufficient to insure the Company against the full amount of liabilities allocated to or retained by it, and Qnity may not be able to satisfy its indemnification obligations in the future. The Company's results of operations could be adversely affected if Qnity cannot or does not perform such obligations.Q4, 2025

DuPont de Nemours Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

GB:0A6B against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SSLSSL71Outperform$7.83B11.267.73%―17.90%95.98%
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
CECE61Neutral$5.29B20.266.35%0.25%1.43%―
DOWDOW60Neutral$21.98B-24.10-4.50%4.61%4.16%20.86%
OLNOLN55Neutral$1.91B-11.13-9.57%4.89%-0.73%-415.18%
HUNHUN49Neutral$1.61B-9.46-6.12%3.88%6.49%47.81%

* Basic Materials Sector Average

Performance Comparison

0%50%100%150%GB:0A6BCEHUNOLNSSLDOWDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
GB:0A6B and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
GB:0A6BDuPont de Nemours, Inc.142.5231.5328.40%
CECelanese48.2112.7636.01%
HUNHuntsman9.031.1114.06%
OLNOlin Corporation16.36-1.44-8.11%
SSLSasol Ltd12.095.2777.27%
DOWDow Inc.30.3710.4152.12%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.